542 related articles for article (PubMed ID: 19114668)
1. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells.
Veldhoen M; Hirota K; Christensen J; O'Garra A; Stockinger B
J Exp Med; 2009 Jan; 206(1):43-9. PubMed ID: 19114668
[TBL] [Abstract][Full Text] [Related]
2. Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells.
Ramirez JM; Brembilla NC; Sorg O; Chicheportiche R; Matthes T; Dayer JM; Saurat JH; Roosnek E; Chizzolini C
Eur J Immunol; 2010 Sep; 40(9):2450-9. PubMed ID: 20706985
[TBL] [Abstract][Full Text] [Related]
3. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells.
Trifari S; Kaplan CD; Tran EH; Crellin NK; Spits H
Nat Immunol; 2009 Aug; 10(8):864-71. PubMed ID: 19578368
[TBL] [Abstract][Full Text] [Related]
4. Impact of culture medium on maturation of bone marrow-derived murine dendritic cells via the aryl hydrocarbon receptor.
Ilchmann A; Krause M; Heilmann M; Burgdorf S; Vieths S; Toda M
Mol Immunol; 2012 May; 51(1):42-50. PubMed ID: 22377453
[TBL] [Abstract][Full Text] [Related]
5. CD69 association with Jak3/Stat5 proteins regulates Th17 cell differentiation.
Martín P; Gómez M; Lamana A; Cruz-Adalia A; Ramírez-Huesca M; Ursa MA; Yáñez-Mo M; Sánchez-Madrid F
Mol Cell Biol; 2010 Oct; 30(20):4877-89. PubMed ID: 20696842
[TBL] [Abstract][Full Text] [Related]
6. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells.
Kimura A; Naka T; Nohara K; Fujii-Kuriyama Y; Kishimoto T
Proc Natl Acad Sci U S A; 2008 Jul; 105(28):9721-6. PubMed ID: 18607004
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals.
Martin B; Hirota K; Cua DJ; Stockinger B; Veldhoen M
Immunity; 2009 Aug; 31(2):321-30. PubMed ID: 19682928
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 through Aryl Hydrocarbon Receptor Regulates IL-22 Response in CD4
Lin X; Tawch S; Wong HT; Roy S; Gaudino S; Castillo P; Elsegeiny W; Wakabayashi N; Oury TD; Pociask D; Chen K; McLinskey N; Melville P; Syritsyna O; Coyle P; Good M; Awasthi A; Kolls JK; Kumar P
J Immunol; 2021 Apr; 206(7):1540-1548. PubMed ID: 33648937
[TBL] [Abstract][Full Text] [Related]
9. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
10. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma.
Yang XO; Pappu BP; Nurieva R; Akimzhanov A; Kang HS; Chung Y; Ma L; Shah B; Panopoulos AD; Schluns KS; Watowich SS; Tian Q; Jetten AM; Dong C
Immunity; 2008 Jan; 28(1):29-39. PubMed ID: 18164222
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P4501-inhibiting chemicals amplify aryl hydrocarbon receptor activation and IL-22 production in T helper 17 cells.
Schiering C; Vonk A; Das S; Stockinger B; Wincent E
Biochem Pharmacol; 2018 May; 151():47-58. PubMed ID: 29501585
[TBL] [Abstract][Full Text] [Related]
12. The role of STAT3 and AhR in the differentiation of CD4+ T cells into Th17 and Treg cells.
Liu X; Hu H; Fan H; Zuo D; Shou Z; Liao Y; Nan Z; Tang Q
Medicine (Baltimore); 2017 Apr; 96(17):e6615. PubMed ID: 28445259
[TBL] [Abstract][Full Text] [Related]
13. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function.
Zhou L; Lopes JE; Chong MM; Ivanov II; Min R; Victora GD; Shen Y; Du J; Rubtsov YP; Rudensky AY; Ziegler SF; Littman DR
Nature; 2008 May; 453(7192):236-40. PubMed ID: 18368049
[TBL] [Abstract][Full Text] [Related]
14. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis.
Singh NP; Singh UP; Singh B; Price RL; Nagarkatti M; Nagarkatti PS
PLoS One; 2011; 6(8):e23522. PubMed ID: 21858153
[TBL] [Abstract][Full Text] [Related]
15. Tetrandrine, an agonist of aryl hydrocarbon receptor, reciprocally modulates the activities of STAT3 and STAT5 to suppress Th17 cell differentiation.
Yuan X; Dou Y; Wu X; Wei Z; Dai Y
J Cell Mol Med; 2017 Sep; 21(9):2172-2183. PubMed ID: 28332288
[TBL] [Abstract][Full Text] [Related]
16. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
17. Aryl Hydrocarbon Receptor Ligands in Cigarette Smoke Induce Production of Interleukin-22 to Promote Pancreatic Fibrosis in Models of Chronic Pancreatitis.
Xue J; Zhao Q; Sharma V; Nguyen LP; Lee YN; Pham KL; Edderkaoui M; Pandol SJ; Park W; Habtezion A
Gastroenterology; 2016 Dec; 151(6):1206-1217. PubMed ID: 27769811
[TBL] [Abstract][Full Text] [Related]
18. Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production.
Lowe MM; Mold JE; Kanwar B; Huang Y; Louie A; Pollastri MP; Wang C; Patel G; Franks DG; Schlezinger J; Sherr DH; Silverstone AE; Hahn ME; McCune JM
PLoS One; 2014; 9(2):e87877. PubMed ID: 24498387
[TBL] [Abstract][Full Text] [Related]
19. T-bet over-expression regulates aryl hydrocarbon receptor-mediated T helper type 17 differentiation through an interferon (IFN)γ-independent pathway.
Yokosawa M; Kondo Y; Tahara M; Iizuka-Koga M; Segawa S; Kaneko S; Tsuboi H; Yoh K; Takahashi S; Matsumoto I; Sumida T
Clin Exp Immunol; 2017 Apr; 188(1):22-35. PubMed ID: 27936495
[TBL] [Abstract][Full Text] [Related]
20. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity.
Klotz L; Burgdorf S; Dani I; Saijo K; Flossdorf J; Hucke S; Alferink J; Nowak N; Beyer M; Mayer G; Langhans B; Klockgether T; Waisman A; Eberl G; Schultze J; Famulok M; Kolanus W; Glass C; Kurts C; Knolle PA
J Exp Med; 2009 Sep; 206(10):2079-89. PubMed ID: 19737866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
